chr19-36067293-C-T

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_001083961.2(WDR62):​c.562-13C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0387 in 1,614,002 control chromosomes in the GnomAD database, including 1,571 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.036 ( 142 hom., cov: 33)
Exomes 𝑓: 0.039 ( 1429 hom. )

Consequence

WDR62
NM_001083961.2 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:9

Conservation

PhyloP100: -0.104

Publications

6 publications found
Variant links:
Genes affected
WDR62 (HGNC:24502): (WD repeat domain 62) This gene is proposed to play a role in cerebral cortical development. Mutations in this gene have been associated with microencephaly, cortical malformations, and cognitive disability. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jan 2011]
WDR62 Gene-Disease associations (from GenCC):
  • microcephaly 2, primary, autosomal recessive, with or without cortical malformations
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), Laboratory for Molecular Medicine, Ambry Genetics, Illumina, G2P, ClinGen
  • autosomal recessive primary microcephaly
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.79).
BP6
Variant 19-36067293-C-T is Benign according to our data. Variant chr19-36067293-C-T is described in ClinVar as Benign. ClinVar VariationId is 160305.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.105 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
WDR62NM_001083961.2 linkc.562-13C>T intron_variant Intron 5 of 31 ENST00000401500.7 NP_001077430.1 O43379-4

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
WDR62ENST00000401500.7 linkc.562-13C>T intron_variant Intron 5 of 31 1 NM_001083961.2 ENSP00000384792.1 O43379-4

Frequencies

GnomAD3 genomes
AF:
0.0357
AC:
5441
AN:
152240
Hom.:
139
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0221
Gnomad AMI
AF:
0.00877
Gnomad AMR
AF:
0.0286
Gnomad ASJ
AF:
0.0643
Gnomad EAS
AF:
0.112
Gnomad SAS
AF:
0.0809
Gnomad FIN
AF:
0.0308
Gnomad MID
AF:
0.0411
Gnomad NFE
AF:
0.0361
Gnomad OTH
AF:
0.0425
GnomAD2 exomes
AF:
0.0463
AC:
11623
AN:
250878
AF XY:
0.0483
show subpopulations
Gnomad AFR exome
AF:
0.0229
Gnomad AMR exome
AF:
0.0205
Gnomad ASJ exome
AF:
0.0652
Gnomad EAS exome
AF:
0.122
Gnomad FIN exome
AF:
0.0328
Gnomad NFE exome
AF:
0.0372
Gnomad OTH exome
AF:
0.0457
GnomAD4 exome
AF:
0.0390
AC:
57022
AN:
1461644
Hom.:
1429
Cov.:
33
AF XY:
0.0404
AC XY:
29354
AN XY:
727134
show subpopulations
African (AFR)
AF:
0.0210
AC:
703
AN:
33478
American (AMR)
AF:
0.0216
AC:
968
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.0681
AC:
1779
AN:
26136
East Asian (EAS)
AF:
0.104
AC:
4137
AN:
39694
South Asian (SAS)
AF:
0.0757
AC:
6530
AN:
86254
European-Finnish (FIN)
AF:
0.0326
AC:
1737
AN:
53310
Middle Eastern (MID)
AF:
0.0459
AC:
265
AN:
5768
European-Non Finnish (NFE)
AF:
0.0342
AC:
37996
AN:
1111892
Other (OTH)
AF:
0.0481
AC:
2907
AN:
60388
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.463
Heterozygous variant carriers
0
3113
6226
9340
12453
15566
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
1504
3008
4512
6016
7520
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0358
AC:
5452
AN:
152358
Hom.:
142
Cov.:
33
AF XY:
0.0362
AC XY:
2694
AN XY:
74504
show subpopulations
African (AFR)
AF:
0.0221
AC:
918
AN:
41584
American (AMR)
AF:
0.0286
AC:
438
AN:
15308
Ashkenazi Jewish (ASJ)
AF:
0.0643
AC:
223
AN:
3470
East Asian (EAS)
AF:
0.112
AC:
582
AN:
5182
South Asian (SAS)
AF:
0.0805
AC:
389
AN:
4832
European-Finnish (FIN)
AF:
0.0308
AC:
327
AN:
10630
Middle Eastern (MID)
AF:
0.0442
AC:
13
AN:
294
European-Non Finnish (NFE)
AF:
0.0361
AC:
2455
AN:
68030
Other (OTH)
AF:
0.0468
AC:
99
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
279
558
838
1117
1396
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
72
144
216
288
360
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0399
Hom.:
31
Bravo
AF:
0.0337
Asia WGS
AF:
0.151
AC:
524
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:9
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:4
-
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Feb 08, 2013
Genetic Services Laboratory, University of Chicago
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:3
Feb 02, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Mar 03, 2015
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Microcephaly 2, primary, autosomal recessive, with or without cortical malformations Benign:2
Dec 05, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.79
CADD
Benign
12
DANN
Benign
0.66
PhyloP100
-0.10
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.070
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs78138007; hg19: chr19-36558195; API